Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours

NMR in Biomedicine

Volumn 8, Issue 6, 1995, Pages 253-264

  Florian, Catarina L ^a   Preece, Nicholas E ^a   Bhakoo, Kishore K ^a   Williams, Stephen R ^a   Noble, Mark ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; CHOLINE; CREATINE; GLUTAMIC ACID;

ARTICLE; BRAIN TUMOR; CELL CULTURE; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MENINGIOMA; METABOLISM; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ALANINE; AMINO ACIDS; BRAIN NEOPLASMS; CHOLINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; GLIOBLASTOMA; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MENINGIOMA; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0029367916     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1940080605     Document Type: Article

References (44)

1. Studies of human tumors by MRS: a review
2. Proton NMR spectroscopy of intracranial tumours: in vivo and in vitro studies
3. Detection of metabolic heterogeneity of human intracranial tumours in vivo by proton NMR spectroscopic imaging
4. Non‐invasive differentiation of tumours with use of localised H‐1 MR spectroscopy in vitro Initial experience in patients with cerebral tumours
5. 1H NMR markers of neuronal and glial disorders
6. High‐resolution 1H‐NMR spectroscopy studies of extracts of human cerebral neoplasms
7. Choline‐containing compounds in human astrocytomas studied by 1H‐NMR spectroscopy in vivo and in vitro
8. 1H NMR spectroscopy
9. 1H‐NMR of acid extracts
10. Further evidence that the narrow proton magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets
11. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
12. 1H NMR spectroscopy
13. Intermediate filaments in meningiomas
14. Immunocytochemistry of intracranial meningiomas
15. Ultrastructural immunogold labelling of vimentin filaments on postembedding ultrathin sections of arachnoid villi and meningiomas
16. Measurement of protein using bicinchoninic acid
17. 1H NMR detection of cerebral myo‐inositol
18. Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 1 guinea pigs
19. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivation with o‐phthaldialdehyde
20. N‐acetyl‐aspartyl‐glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method
21. Induction of the ganglioside marker A2B5 on cultured cerebellar neural cells by growth factors
22. Expression of glial fibrillary acidic protein, vimentin, fibronectin and N‐myc oncoprotein in primary human brain tumor cell explants
23. Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas
24. Bi‐modal differentiation pattern in a new human neuroblastoma cell line in vitro
25. Molecular biology and genetics of neuroblastoma
26. In vivo, ex vivo, and in vitro one‐and two‐dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances
27. High‐resolution one‐and two‐dimensional 1H‐MRS of human brain tumour and normal glial cells
28. Application of in vivo NMR spectroscopy to cancer
29. 31P NMR spectroscopy
30. Phospholipid and energy metabolism of cancer cells monitored by phosphorus magnetic resonance spectroscopy: possible clinical significance
31. Clinical phorphorus‐CSI in preoperative embolization therapy of meningioma
32. NMR study of phospholipid metabolism of human meningioma
33. 31P chemical shift imaging of the human brain in normal volunteers
34. 1H NMR spectroscopy of human brain. Water suppression, short echo times and 1 mL resolution
35. Classification of tumour 1H NMR spectra by pattern recognition
36. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples
37. Pattern recognition of 31P MRS of tumour spectra obtained in vivo
38. Computerized consensus diagnosis—a classification strategy for the robust analysis of MR spectra. 1. Application to 1H spectra of thyroid neoplasms
39. 1H nuclear magnetic resonance spectra by the application of chemometric techniques
40. 1H‐NMR spectra